Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I/II trial of topical jaktinib hydrochloride cream for mild to moderate alopecia areata
CTR20192468Phase 2Completed
- Sponsor
- Zelgen
- Start
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of jaktinib in alopecia areata, sponsored by Zelgen. Started Aug 2020; status: completed.
02
Drugs
jaktinib
03
Conditions
alopecia areata
Beyond the preview
Go deeper on CTR20192468.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20192468.